Why Analysts Revised Sales for Aurora Cannabis

With the anticipation of marijuana legalization in Canada in the coming months, most of the sales will be captured in fiscal 2019. In the above chart, you can see that the overall sales estimates for fiscal 2019 for most of the cannabis producers have risen from ~1.1 billion Canadian dollars to ~1.7 billion Canadian dollars over the past six months. Looking at the chart, we see that Cronos Group (CRON), CannTrust Holdings (CNTTF), Hydropothecary (HYYDF), and Aurora Cannabis (ACB) (ACBFF) have had the largest percentage changes in sales revisions over the past six months.